Horizon Therapeutics: 2Q Earnings Snapshot
DUBLIN (AP) _ Horizon Therapeutics Public Limited Company (HZNP) on Wednesday reported a loss of $5.1 million in its second quarter.
On a per-share basis, the Dublin-based company said it had a loss of 3 cents. Earnings, adjusted for amortization costs and non-recurring costs, were 52 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 38 cents per share.
The drugmaker posted revenue of $320.6 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $298.8 million.
Horizon Therapeutics expects full-year revenue in the range of $1.28 billion to $1.3 billion.
Horizon Therapeutics shares have risen 21% since the beginning of the year. The stock has increased 31% in the last 12 months.